Merck Tbk. vs Triwira Insanlestari Tbk. — how do they compare? Merck Tbk. trades at Rp3,900 (market cap 1.76T, 63K 24h volume), while Triwira Insanlestari Tbk. trades at Rp50 (market cap 60B). The key difference: Merck Tbk. is far larger — about 29.3× Triwira Insanlestari Tbk.'s market cap. Which is the better fit depends on your goals.
| MERK | TRIL | |
|---|---|---|
Market Cap | 1.76T | 60B |
Volume | 63K | — |
Lot | 630 | — |
Turnover | 243.97M | — |
Average Price | 3,872.46 | — |
Value | 243.97M | — |
Indicative Equilibrium Price | 3,900 | — |
Indicative Equilibrium Volume | 1 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →PT Triwira Insanlestari Tbk (the company) was established on 26 Oct 1992 based on Notaries Deed No. 185 of Erny Tjandrasasmita, S.H.The Companys articles of association has been amended several times, most recently by notarial deed No. 6 of Lenny Janis Ishak, S.H., dated Sep 17, 2007, concerning among others, the change company's name, par value and public offering.
Read more on TRIL →